KNSA logo

KNSA

Kiniksa Pharmaceuticals, Ltd.NASDAQHealthcare
$48.82+1.50%ClosedMarket Cap: $3.62B

As of 2026-04-06

Insider Statistics (Q2 2026)

Purchases

24

Sales

24

Buy/Sell Ratio

1.00

Total Bought

$0.00

Total Sold

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri Apr 03Ragosa Markofficer: CHIEF FINANCIAL OFFICERSell31,150$48.1331,150
Fri Apr 03Tessari Ebenofficer: CHIEF STRATEGY OFFICERSell365$24.1617,031
Fri Apr 03Tessari Ebenofficer: CHIEF STRATEGY OFFICERSell16,600$0.0016,600
Fri Apr 03Tessari Ebenofficer: CHIEF STRATEGY OFFICERSell8,300$0.008,300
Fri Apr 03Tessari Ebenofficer: CHIEF STRATEGY OFFICERSell2,457$0.007,371
Fri Apr 03Tessari Ebenofficer: CHIEF STRATEGY OFFICERSell1,745$0.003,490
Fri Apr 03Tessari Ebenofficer: CHIEF STRATEGY OFFICERSell1,773$0.001,772
Fri Apr 03Tessari Ebenofficer: CHIEF STRATEGY OFFICERSell33,200$48.1333,200
Fri Apr 03Tessari Ebenofficer: CHIEF STRATEGY OFFICERSell5,975$0.0023,006
Fri Apr 03Tessari Ebenofficer: CHIEF STRATEGY OFFICERSell1,756$48.1321,250
Wed Mar 11Ragosa Markofficer: CHIEF FINANCIAL OFFICERSell13,813$18.0638,448
Wed Mar 11Ragosa Markofficer: CHIEF FINANCIAL OFFICERSell17,981$45.5830,827
Wed Mar 11Ragosa Markofficer: CHIEF FINANCIAL OFFICERSell10,513$17.7624,635
Wed Mar 11Ragosa Markofficer: CHIEF FINANCIAL OFFICERSell2,036$22.8914,122
Wed Mar 11Ragosa Markofficer: CHIEF FINANCIAL OFFICERSell18,741$46.2412,086